Skip to main content

TCG — Portfolio, Page 5

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

147
Companies
$1.7B
Total invested
$31.7M
Avg. check
31
Industries
Biotechnology 17Therapeutics 10Health Care 9Medical 9Pharmaceutical 5Life Science 4+25 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 97120 of 147
Korsana Biosciences
September 2025

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Biopharma · Waltham$150.0M Series A
Plexium
August 2025

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

Biotechnology · San Diego$60.1M Series C
Abivax
July 2025

Abivax develops medicines that alter the body's natural immune system mechanisms.

Biotechnology · Paris$747.5M Post Ipo Equity
Unrivaled Sports
May 2025

Unrivaled Sports manages a diverse portfolio of youth sports properties in Baseball, Softball, Football, and Action Sports.

American Football · New York$120.0M Series Unknown
Arbor Biotechnologies
March 2025

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

Artificial Intelligence (AI) · Cambridge$73.9M Series C
audiochuck
February 2025

audiochuck is a media company that creates and produces content.

Digital Media · Indianapolis$40.0M Private Equity
ADARx Pharmaceuticals
February 2025

ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.

Biotechnology · San DiegoSeries Unknown
Inhibrx
January 2025

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

Biotechnology · La Jolla$150.0M Post Ipo Debt
Sphere
December 2024

The operating system for stablecoins.

B2B · Boston$5.0M Series Unknown
ADCendo
November 2024

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

Biotechnology · Copenhagen$135.0M Series B
Avalo Therapeutics
November 2024

Avalo Therapeutics is a clinical-stage biopharmaceutical company.

Biotechnology · Rockville$69.4M Post Ipo Equity
Judo Bio
October 2024

Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.

Biotechnology · Cambridge$75.0M Series A
Vicebio
September 2024

Vicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology.

Biotechnology · London$100.0M Series B
Pathalys Pharma
August 2024

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Biopharma · Raleigh$105.0M Series B
Entrada Therapeutics
June 2024

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Biotechnology · Boston$100.0M Post Ipo Equity
Tourmaline Bio
January 2024

Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.

Biotechnology · New York$172.5M Post Ipo Equity
Alpine Immune Sciences
November 2023

Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.

Biotechnology · Seattle$150.0M Post Ipo Equity
Better Place Forests
August 2023

Better Place Forests provides memorial spreading forests for families who choose cremation.

Family · San Francisco$7.8M Series Unknown
Upstream Bio
June 2023

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Biotechnology · Waltham$200.0M Series B
Alkeus Pharmaceuticals
June 2023

Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.

Biotechnology · Cambridge$150.0M Series B
Cars & Bids
January 2023

Cars & Bids is an online auction marketplace to buy and sell modern enthusiast cars.

Automotive · San Diego$37.0M Series A
Synthekine
January 2023

Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.

Biotechnology · Menlo Park$100.0M Series C
POAP
January 2023

POAP: "Proof of Attendance Protocol. The ecosystem to preserve life experiences as digital collectibles.

Blockchain · New YorkSeed
Outdefine
December 2022

Outdefine is a tokenized hiring network for the world's talent.

Blockchain · San Francisco$2.5M Seed

Where TCG invests

Biotechnology17
Therapeutics10
Health Care9
Medical9
Pharmaceutical5
Life Science4

About TCG's portfolio

How many companies has TCG invested in?

TCG has invested in 147 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does TCG invest in?

TCG's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Pharmaceutical. The firm invests across 31 different industry categories.

What is TCG's largest investment?

Among tracked funding rounds, Abivax received $747.5M in a Post Ipo Equity round. TCG's total known invested capital is $1.7B.

What is the average investment size for TCG?

TCG's average investment size is $31.7M across its portfolio of 147 companies.

What are TCG's most recent investments?

Recent TCG portfolio additions include Korsana Biosciences, Plexium, Abivax, Unrivaled Sports, Arbor Biotechnologies. These companies were founded in 2020 or later.

Reach the founders behind these 147 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →